Hspa5 Mouse shRNA Plasmid (Locus ID 14828)
CAT#: TL500881
Hspa5 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | Hspa5 Mouse shRNA Plasmid (Locus ID 14828) |
Locus ID | 14828 |
UniProt ID | P20029 |
Synonyms | AL022860; AU019543; baffled; Bip; D2Wsu17e; D2Wsu141e; Grp78; Hsce70; mBiP; SEZ-7; Sez7 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | Hspa5 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 14828). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | BC050927, NM_001163434, NM_022310, NM_001163434.1, NM_022310.1, NM_022310.2, NM_022310.3, BC005785 |
Summary | Endoplasmic reticulum chaperone that plays a key role in protein folding and quality control in the endoplasmic reticulum lumen (PubMed:12411443, PubMed:12475965). Involved in the correct folding of proteins and degradation of misfolded proteins via its interaction with DNAJC10/ERdj5, probably to facilitate the release of DNAJC10/ERdj5 from its substrate (PubMed:12411443). Acts as a key repressor of the ERN1/IRE1-mediated unfolded protein response (UPR) (By similarity). In the unstressed endoplasmic reticulum, recruited by DNAJB9/ERdj4 to the luminal region of ERN1/IRE1, leading to disrupt the dimerization of ERN1/IRE1, thereby inactivating ERN1/IRE1 (By similarity). Accumulation of misfolded protein in the endoplasmic reticulum causes release of HSPA5/BiP from ERN1/IRE1, allowing homodimerization and subsequent activation of ERN1/IRE1 (By similarity). Plays an auxiliary role in post-translational transport of small presecretory proteins across endoplasmic reticulum (ER). May function as an allosteric modulator for SEC61 channel-forming translocon complex, likely cooperating with SEC62 to enable the productive insertion of these precursors into SEC61 channel. Appears to specifically regulate translocation of precursors having inhibitory residues in their mature region that weaken channel gating.[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
ER translocation of the MAPK pathway drives therapy resistance in BRAF mutant melanoma
,Ojha, R;Leli, NM;Onorati, A;Piao, S;Verginadis, II;Tameire, F;Rebecca, VW;Chude, CI;Murugan, S;Fennelly, C;Noguera-Ortega, E;Liu, S;Xu, X;Krepler, C;Xiao, M;Xu, W;Wei, Z;Frederick, DT;Boland, G;Mitchell, TC;Karakousis, GC;Schuchter, LM;Flaherty, KT;Zhang, G;Herlyn, M;Koumenis, C;Amaravadi, RK;,
Cancer Discov
,PubMed ID 30563872
[HSPA5]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...